Efficacy and Safety of Trans Sodium Crocetinate (TSC) for Treatment of Suspected Stroke

Phase 2 Terminated 6 enrolled Diffusion Pharmaceuticals Inc University of California, Los Angeles · collab University of Virginia · collab

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will assess the potential efficacy and safety of TSC as early treatment for both ischemic and hemorrhagic stroke when administered while subject is in ambulance being transported to hospital.

Timeline

Start: 2019-08-22
Primary completion: 2020-10-19
Completion: 2020-10-19

Publications

Zachrison KS, Amati V, Schwamm LH, Yan Z, Nielsen V, Christie A, Reeves MJ, Sauser JP, Lomi A, Onnela JP. Influence of Hospital Characteristics on Hospital Transfer Destinations for Patients With Stroke. Circ Cardiovasc Qual Outcomes. 2022 May;15(5):e008269. doi: 10.1161/CIRCOUTCOMES.121.008269. Epub 2022 Apr 4.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Trans Sodium Crocetinate	Other / unclassified	0.25 mg/kg	Intravenous

Efficacy and Safety of Trans Sodium Crocetinate (TSC) for Treatment of Suspected Stroke

Summary

Timeline

Publications

Drugs

Indications